Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells

Oncogene

Volumn 23, Issue 46, 2004, Pages 7651-7659

  Kim, Isaac Yi ^a,b,e   Lee, Dong Hyeon ^c   Lee, Dug Keun ^b   Ahn, Han Jong ^d   Kim, Moses M ^a   Kim, Seong Jin ^b   Morton Jr , Ronald A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Ewha Womans University   (South Korea)

^d Asan Medical Center   (South Korea)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BMP; BMP receptors; Prostate cancer

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; MEMBRANE RECEPTOR; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CARCINOGENICITY; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FAMILY; SCORING SYSTEM; SIGNAL TRANSDUCTION; SURVIVAL RATE;

BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 7044221776     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207924     Document Type: Article

References (33)

1. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE and Hamdy FC. (1998). Br. J. Cancer, 78, 1219-1223.
2. Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepel J and Neckers L. (1995). Cancer Res., 55, 4623-4626.
3. Brubaker KD, Corey E, Brown LG and Vessella RL. (2004). J. Cell Biochem., 91, 151-160.
4. Buckley S, Shi W, Driscoll B, Ferrario A, Anderson K and Warburton D. (2004). Am. J. Physiol. Lung Cell Mol. Physiol., 286, L81-86.
5. Derynck R, Akhurst RJ and Balmain A. (2001). Nat Genet., 29, 117-129.
6. Foletta VC, Lim MA, Soosairaiah J, Kelly AP, Stanley EG, Shannon M, He W, Das Supratik, Massague J and Bernard O. (2003). J. Cell Biol., 162, 1089-1098.
7. Hamdy FC, Autzen P, Robinson MC, Horne CH, Neal DE and Robson CN. (1997). Cancer Res., 57, 4427-4431.
8. Harris SE, Harris MA, Mahy P, Wozney J, Feng JQ and Mundy GR. (1994). Prostate, 24, 204-211.
9. Hogan BL. (1996). Genes Dev., 10, 1540-1594.
10. Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ and Sutherland RL. (2004). Prostate, 59, 234-242.
11. Ide H, Katoh M, Sasaki H, Yoshida T, Aoki K, Nawa Y, Osada Y, Sugimura T and Terada M. (1997a). Oncogene, 14, 1377-1382.
12. Ide H, Yoshida T, Matsumoto N, Aoki K, Osada Y, Sugimura T and Terada M. (1997b). Cancer Res., 57, 5022-5027.
13. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ. (2003). CA. Cancer J. Clin., 53, 5-26.
14. Kawamura C, Kizaki M and Ikeda Y. (2002). Leuk. Lymphoma, 43, 635-639.
15. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M and Lee C. (1996). Cancer Res., 56, 44-48.
16. Kim IY, Lee D-H, Ahn H-J, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK and Morton RA. (2000). Cancer Res., 60, 2840-2844.
17. Kim IY, Lee DH, Lee DK, Kim BC, Kim HT, Leach FS, Linehan WM, Morton RA and Kim SJ. (2003). Clin. Cancer Res., 9, 6046-6051.
18. Lamm MI, Podlasek CA, Barret DH, Lee J, Clemens JQ, Hebner CM and Bushman W. (2001). Dev. Biol., 232, 301-314.
19. Liu F, Ventura F, Doody J and Massague J. (1995). Mol. Cell Biol., 15, 3479-3486.
20. Masuda H, Fukabori Y, Nakano K, Shimizu N and Yamanaka H. (2004). Prostate, 59, 101-106.
21. Masuda H, Fukabori Y, Nakano K, Takezawa Y, Suzuki T and Yamanaka H. (2003). Prostate, 54, 268-274.
22. Pouliot F, Blais A and Labrie C. (2003). Cancer Res., 63, 277-281.
23. Rudarakanchana N, Flanagan JA, Chen H, Upton PD, Machado R, Patel D, Trembath RC and Morrell NW. (2002). Hum. Mol. Genet., 11, 1517-1525.
24. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM and Pang RHL. (1992). J. Bio. Chem., 267, 20352-20362.
25. Sintich SM, Lamm ML, Sensibar JA and Lee C. (1999). Endocrinology, 140, 3411-3415.
26. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Esterez M, Riddle DL, Ichijo H, Heldin CH and Miyazono K. (1994). J. Biol. Chem., 269, 16988-16989.
27. Thomas R, Anderson WA, Raman V and Reddi AH. (1998). Prostate, 37, 236-245.
28. Wen XZ, Miyake S, Akiyama Y and Yuasa Y. (2004). Biochem. Biophys. Res. Commun., 316, 100-106.
29. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM and Wang FA. (1988). Science, 242, 1528-1534.
30. Yamada N, Kato M, ten Dijke P, Yamashita H, Sampath TK, Heldin CH, Miyazono K and Funa K. (1996). Br. J. Cancer, 73, 624-629.
31. Yamashita H, ten Dijke P, Heldin CH and Miyazono K. (1996). Bone, 19, 569-574.
32. Yonemori K, Imamura T, Ishidou Y, Okano T, Matsunaga S, Yoshida H, Kato M, Sampath TK, Miyazono K, ten Dijke P and Sakou T. (1997). Am. J. Pathol., 150, 1335-1347.
33. Zhao G-Q. (2003). Genesis, 35, 43-56.